MASLD in Adults With Type 1 Diabetes and Type 2 Diabetes Undergoing Vibration‐Controlled Transient Elastography

There is limited evidence on the prevalence of, and factors contributing to, metabolic dysfunction-associated steatotic liver disease (MASLD) among individuals with type 1 (T1DM) and type 2 (T2DM) diabetes mellitus.

We consecutively enrolled 1304 adult individuals with T1DM (n = 237) or T2DM (n = 1067) who underwent vibration-controlled transient elastography (VCTE) with liver stiffness measurement (LSM) and controlled attenuation parameter (CAP) assessment. MASLD was defined as a CAP ≥ 248 dB/m in the presence of diabetes. Significant and advanced liver fibrosis were defined as LSM ≥ 8 kPa and ≥ 10 kPa, respectively.